Benzodiazepine receptor quantification in Huntington's disease with [(123)I]iomazenil and SPECT

OBJECTIVES—Increasing evidence suggests that metabolic changes predate neuronal death in Huntington's disease and emission tomography methods (PET and SPECT) have shown changes in glucose consumption and receptor function in early and possibly even presymptomatic disease. Because the GABA(A)-be...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Pinborg, L, Videbak, C, Hasselbalch, S, Sorensen, S, Wagner, A, Paulson, O, Knudsen, G
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Group 2001
Schlagworte:
Papers
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1737353/
https://ncbi.nlm.nih.gov/pubmed/11309461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.70.5.657
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge